Skip to main content
Top
Published in: Virology Journal 1/2008

Open Access 01-12-2008 | Research

Conserved positive selection signals in gp41 across multiple subtypes and difference in selection signals detectable in gp41 sequences sampled during acute and chronic HIV-1 subtype C infection

Authors: Gama P Bandawe, Darren P Martin, Florette Treurnicht, Koleka Mlisana, Salim S Abdool Karim, Carolyn Williamson, The CAPRISA 002 Acute Infection Study Team

Published in: Virology Journal | Issue 1/2008

Login to get access

Abstract

Background

The high diversity of HIV variants driving the global AIDS epidemic has caused many to doubt whether an effective vaccine against the virus is possible. However, by identifying the selective forces that are driving the ongoing diversification of HIV and characterising their genetic consequences, it may be possible to design vaccines that pre-empt some of the virus' more common evasion tactics. One component of such vaccines might be the envelope protein, gp41. Besides being targeted by both the humoral and cellular arms of the immune system this protein mediates fusion between viral and target cell membranes and is likely to be a primary determinant of HIV transmissibility.

Results

Using recombination aware analysis tools we compared site specific signals of selection in gp41 sequences from different HIV-1 M subtypes and circulating recombinant forms and identified twelve sites evolving under positive selection across multiple major HIV-1 lineages. To identify evidence of selection operating during transmission our analysis included two matched datasets sampled from patients with acute or chronic subtype C infections. We identified six gp41 sites apparently evolving under different selection pressures during acute and chronic HIV-1 infections. These sites mostly fell within functional gp41 domains, with one site located within the epitope recognised by the broadly neutralizing antibody, 4E10.

Conclusion

Whereas these six sites are potentially determinants of fitness and are therefore good candidate targets for subtype-C specific vaccines, the twelve sites evolving under diversifying selection across multiple subtypes might make good candidate targets for broadly protective vaccines.
Appendix
Available only for authorised users
Literature
1.
go back to reference Martin D, Williamson C: Human immunodeficiency virus – one of nature's greatest evolutionary machines. South African Journal of Science 2004,100(9–10):479-482. Martin D, Williamson C: Human immunodeficiency virus – one of nature's greatest evolutionary machines. South African Journal of Science 2004,100(9–10):479-482.
2.
go back to reference Yang ZH, Bielawski JP: Statistical methods for detecting molecular adaptation. Trends in Ecology & Evolution 2000,15(12):496-503. 10.1016/S0169-5347(00)01994-7 Yang ZH, Bielawski JP: Statistical methods for detecting molecular adaptation. Trends in Ecology & Evolution 2000,15(12):496-503. 10.1016/S0169-5347(00)01994-7
3.
go back to reference Yang ZH, Nielsen R, Goldman N, Pedersen AMK: Codon-substitution models for heterogeneous selection pressure at amino acid sites. Genetics 2000,155(1):431-449.PubMedCentralPubMed Yang ZH, Nielsen R, Goldman N, Pedersen AMK: Codon-substitution models for heterogeneous selection pressure at amino acid sites. Genetics 2000,155(1):431-449.PubMedCentralPubMed
4.
go back to reference Zhang JZ, Zhang YP, Rosenberg HF: Adaptive evolution of a duplicated pancreatic ribonuclease gene in a leaf-eating monkey. Nature Genetics 2002,30(4):411-415. 10.1038/ng852PubMed Zhang JZ, Zhang YP, Rosenberg HF: Adaptive evolution of a duplicated pancreatic ribonuclease gene in a leaf-eating monkey. Nature Genetics 2002,30(4):411-415. 10.1038/ng852PubMed
5.
go back to reference Richman DD, Wrin T, Little SJ, Petropoulos CJ: Rapid evolution of the neutralizing antibody response to HIV type 1 infection. Proceedings of the National Academy of Sciences of the United States of America 2003,100(7):4144-4149. 10.1073/pnas.0630530100PubMedCentralPubMed Richman DD, Wrin T, Little SJ, Petropoulos CJ: Rapid evolution of the neutralizing antibody response to HIV type 1 infection. Proceedings of the National Academy of Sciences of the United States of America 2003,100(7):4144-4149. 10.1073/pnas.0630530100PubMedCentralPubMed
6.
go back to reference Zhang LQ, Mackenzie P, Cleland A, Holmes EC, Brown AJL, Simmonds P: Selection for Specific Sequences in the External Envelope Protein of Human-Immunodeficiency-Virus Type-1 Upon Primary Infection. Journal of Virology 1993,67(6):3345-3356.PubMedCentralPubMed Zhang LQ, Mackenzie P, Cleland A, Holmes EC, Brown AJL, Simmonds P: Selection for Specific Sequences in the External Envelope Protein of Human-Immunodeficiency-Virus Type-1 Upon Primary Infection. Journal of Virology 1993,67(6):3345-3356.PubMedCentralPubMed
7.
go back to reference Allen TM, O'Connor DH, Jing PC, Dzuris JL, Mothe BR, Vogel TU, Dunphy E, Liebl ME, Emerson C, Wilson N, Kunstman KJ, Wang XC, Allison DB, Hughes AL, Desrosiers RC, Altman JD, Wolinsky SM, Sette A, Watkins DI: Tat-specific cytotoxic T lymphocytes select for SIV escape variants during resolution of primary viraemia. Nature 2000,407(6802):386-390. 10.1038/35030124PubMed Allen TM, O'Connor DH, Jing PC, Dzuris JL, Mothe BR, Vogel TU, Dunphy E, Liebl ME, Emerson C, Wilson N, Kunstman KJ, Wang XC, Allison DB, Hughes AL, Desrosiers RC, Altman JD, Wolinsky SM, Sette A, Watkins DI: Tat-specific cytotoxic T lymphocytes select for SIV escape variants during resolution of primary viraemia. Nature 2000,407(6802):386-390. 10.1038/35030124PubMed
8.
go back to reference da Silva J, Hughes AL: Molecular phylogenetic evidence of cytotoxic T lymphocyte (CTL) selection on human immunodeficiency virus type 1 (HIV-1). Mol Biol Evol 1999,16(10):1420-1422.PubMed da Silva J, Hughes AL: Molecular phylogenetic evidence of cytotoxic T lymphocyte (CTL) selection on human immunodeficiency virus type 1 (HIV-1). Mol Biol Evol 1999,16(10):1420-1422.PubMed
9.
go back to reference Evans DT, Knapp LA, Jing PC, Mitchen JL, Dykhuizen M, Montefiori DC, Pauza CD, Watkins DI: Rapid and slow progressors differ by a single MHC class I haplotype in a family of MHC-defined rhesus macaques infected with SIV. Immunology Letters 1999,66(1–3):53-59. 10.1016/S0165-2478(98)00151-5PubMed Evans DT, Knapp LA, Jing PC, Mitchen JL, Dykhuizen M, Montefiori DC, Pauza CD, Watkins DI: Rapid and slow progressors differ by a single MHC class I haplotype in a family of MHC-defined rhesus macaques infected with SIV. Immunology Letters 1999,66(1–3):53-59. 10.1016/S0165-2478(98)00151-5PubMed
10.
go back to reference Goulder P, Price D, Nowak M, RowlandJones S, Phillips R, McMichael A: Co-evolution of human immunodeficiency virus and cytotoxic T-lymphocyte responses. Immunological Reviews 1997, 159: 17-29. 10.1111/j.1600-065X.1997.tb01004.xPubMed Goulder P, Price D, Nowak M, RowlandJones S, Phillips R, McMichael A: Co-evolution of human immunodeficiency virus and cytotoxic T-lymphocyte responses. Immunological Reviews 1997, 159: 17-29. 10.1111/j.1600-065X.1997.tb01004.xPubMed
11.
go back to reference Moore CB, John M, James IR, Christiansen FT, Witt CS, Mallal SA: Evidence of HIV-1 adaptation to HLA-restricted immune responses at a population level. Science 2002,296(5572):1439-1443. 10.1126/science.1069660PubMed Moore CB, John M, James IR, Christiansen FT, Witt CS, Mallal SA: Evidence of HIV-1 adaptation to HLA-restricted immune responses at a population level. Science 2002,296(5572):1439-1443. 10.1126/science.1069660PubMed
12.
go back to reference O'Connor D, Friedrich T, Hughes A, Allen TM, Watkins D: Understanding cytotoxic T-lymphocyte escape during simian immunodeficiency virus infection. Immunological Reviews 2001, 183: 115-126. 10.1034/j.1600-065x.2001.1830110.xPubMed O'Connor D, Friedrich T, Hughes A, Allen TM, Watkins D: Understanding cytotoxic T-lymphocyte escape during simian immunodeficiency virus infection. Immunological Reviews 2001, 183: 115-126. 10.1034/j.1600-065x.2001.1830110.xPubMed
13.
go back to reference Piontkivska H, Hughes AL: Between-host evolution of cytotoxic T-lymphocyte epitopes in human immunodeficiency virus type 1: an approach based on phylogenetically independent comparisons. Journal of Virology 2004,78(21):11758-11765. 10.1128/JVI.78.21.11758-11765.2004PubMedCentralPubMed Piontkivska H, Hughes AL: Between-host evolution of cytotoxic T-lymphocyte epitopes in human immunodeficiency virus type 1: an approach based on phylogenetically independent comparisons. Journal of Virology 2004,78(21):11758-11765. 10.1128/JVI.78.21.11758-11765.2004PubMedCentralPubMed
14.
go back to reference Edwards CTT, Holmes EC, Pybus OG, Wilson DJ, Viscidi RP, Abrams EJ, Phillips RE, Drummond AJ: Evolution of the human immunodeficiency virus envelope gene is dominated by purifying selection. Genetics 2006,174(3):1441-1453. 10.1534/genetics.105.052019PubMedCentralPubMed Edwards CTT, Holmes EC, Pybus OG, Wilson DJ, Viscidi RP, Abrams EJ, Phillips RE, Drummond AJ: Evolution of the human immunodeficiency virus envelope gene is dominated by purifying selection. Genetics 2006,174(3):1441-1453. 10.1534/genetics.105.052019PubMedCentralPubMed
15.
go back to reference Meissner EG, Coffield VM, Su LS: Thymic pathogenicity of an HIV-1 envelope is associated with increased CXCR4 binding efficiency and V5-gp41-dependent activity, but not V1/N2-associated CD4 binding efficiency and viral entry. Virology 2005,336(2):184-197. 10.1016/j.virol.2005.03.032PubMedCentralPubMed Meissner EG, Coffield VM, Su LS: Thymic pathogenicity of an HIV-1 envelope is associated with increased CXCR4 binding efficiency and V5-gp41-dependent activity, but not V1/N2-associated CD4 binding efficiency and viral entry. Virology 2005,336(2):184-197. 10.1016/j.virol.2005.03.032PubMedCentralPubMed
16.
go back to reference Lambele M, Labrosse B, Roch E, Moreau A, Verrier B, Barin F, Roingeard P, Mammano F, Brand D: Impact of natural polymorphism within the gp41 cytoplasmic tail of human immunodeficiency virus type 1 on the intracellular distribution of envelope glycoproteins and viral assembly. Journal of Virology 2007,81(1):125-140. 10.1128/JVI.01659-06PubMedCentralPubMed Lambele M, Labrosse B, Roch E, Moreau A, Verrier B, Barin F, Roingeard P, Mammano F, Brand D: Impact of natural polymorphism within the gp41 cytoplasmic tail of human immunodeficiency virus type 1 on the intracellular distribution of envelope glycoproteins and viral assembly. Journal of Virology 2007,81(1):125-140. 10.1128/JVI.01659-06PubMedCentralPubMed
17.
go back to reference Martin I, Schaal H, Scheid A, Ruysschaert JM: Lipid membrane fusion induced by the human immunodeficiency virus type 1 gp41 N-terminal extremity is determined by its orientation in the lipid bilayer. Journal of Virology 1996,70(1):298-304.PubMedCentralPubMed Martin I, Schaal H, Scheid A, Ruysschaert JM: Lipid membrane fusion induced by the human immunodeficiency virus type 1 gp41 N-terminal extremity is determined by its orientation in the lipid bilayer. Journal of Virology 1996,70(1):298-304.PubMedCentralPubMed
18.
go back to reference Mobley PW, Waring AJ, Sherman MA, Gordon LM: Membrane interactions of the synthetic N-terminal peptide of HIV-1 gp41 and its structural analogs. Biochimica et Biophysica Acta-Biomembranes 1999,1418(1):1-18. 10.1016/S0005-2736(99)00014-0 Mobley PW, Waring AJ, Sherman MA, Gordon LM: Membrane interactions of the synthetic N-terminal peptide of HIV-1 gp41 and its structural analogs. Biochimica et Biophysica Acta-Biomembranes 1999,1418(1):1-18. 10.1016/S0005-2736(99)00014-0
19.
go back to reference Charloteaux B, Lorin A, Crowet JM, Stroobant V, Lins L, Thomas A, Brasseur R: The N-terminal 12 residue long peptide of HIV gp41 is the minimal peptide sufficient to induce significant T-cell-like membrane destabilization in vitro. Journal of Molecular Biology 2006,359(3):597-609. 10.1016/j.jmb.2006.04.018PubMed Charloteaux B, Lorin A, Crowet JM, Stroobant V, Lins L, Thomas A, Brasseur R: The N-terminal 12 residue long peptide of HIV gp41 is the minimal peptide sufficient to induce significant T-cell-like membrane destabilization in vitro. Journal of Molecular Biology 2006,359(3):597-609. 10.1016/j.jmb.2006.04.018PubMed
20.
go back to reference Dey AK, David KB, Klasse PJ, Moore JP: Specific amino acids in the N-terminus of the gp41 ectodomain contribute to the stabilization of a soluble, cleaved gp140 envelope glycoprotein from human immunodeficiency virus type 1. Virology 2007,360(1):199-208. 10.1016/j.virol.2006.09.046PubMedCentralPubMed Dey AK, David KB, Klasse PJ, Moore JP: Specific amino acids in the N-terminus of the gp41 ectodomain contribute to the stabilization of a soluble, cleaved gp140 envelope glycoprotein from human immunodeficiency virus type 1. Virology 2007,360(1):199-208. 10.1016/j.virol.2006.09.046PubMedCentralPubMed
21.
go back to reference Hsu M, Harouse JM, Gettie A, Buckner C, Blanchard J, Cheng-Mayer C: Increased mucosal transmission but not enhanced pathogenicity of the CCR5-tropic, simian AIDS-inducing simian/human immunodeficiency virus SHIVSF162P3 maps to envelope gp120. Journal of Virology 2003,77(2):989-998. 10.1128/JVI.77.2.989-998.2003PubMedCentralPubMed Hsu M, Harouse JM, Gettie A, Buckner C, Blanchard J, Cheng-Mayer C: Increased mucosal transmission but not enhanced pathogenicity of the CCR5-tropic, simian AIDS-inducing simian/human immunodeficiency virus SHIVSF162P3 maps to envelope gp120. Journal of Virology 2003,77(2):989-998. 10.1128/JVI.77.2.989-998.2003PubMedCentralPubMed
22.
go back to reference Liu Y, Curlin ME, Diem K, Zhao H, Ghosh AK, Zhu HY, Woodward AS, Maenza J, Stevens CE, Stekler J, Collier AC, Genowati I, Deng WJ, Zioni R, Corey L, Zhu TF, Mullins JI: Env length and N-linked glycosylation following transmission of human immunodeficiency virus Type 1 subtype B viruses. Virology 2008,374(2):229-233. 10.1016/j.virol.2008.01.029PubMedCentralPubMed Liu Y, Curlin ME, Diem K, Zhao H, Ghosh AK, Zhu HY, Woodward AS, Maenza J, Stevens CE, Stekler J, Collier AC, Genowati I, Deng WJ, Zioni R, Corey L, Zhu TF, Mullins JI: Env length and N-linked glycosylation following transmission of human immunodeficiency virus Type 1 subtype B viruses. Virology 2008,374(2):229-233. 10.1016/j.virol.2008.01.029PubMedCentralPubMed
23.
go back to reference Keele BF, Giorgi EE, Salazar-Gonzalez JF, Decker JM, Pham KT, Salazar MG, Sun CX, Grayson T, Wang SY, Li H, Wei XP, Jiang CL, Kirchherr JL, Gao F, Anderson JA, Ping LH, Swanstrom R, Tomaras GD, Blattner WA, Goepfert PA, Kilby JM, Saag MS, Delwart EL, Busch MP, Cohen MS, Montefiori DC, Haynes BF, Gaschen B, Athreya GS, Lee HY, Wood N, Seoighe C, Perelson AS, Bhattacharya T, Korber BT, Hahn BH, Shaw GM: Identification and characterisation of transmitted and early founder virus envelopes in primary HIV-1 infection. Proceedings of the National Academy of Sciences of the United States of America 2008,105(21):7552-7557. 10.1073/pnas.0802203105PubMedCentralPubMed Keele BF, Giorgi EE, Salazar-Gonzalez JF, Decker JM, Pham KT, Salazar MG, Sun CX, Grayson T, Wang SY, Li H, Wei XP, Jiang CL, Kirchherr JL, Gao F, Anderson JA, Ping LH, Swanstrom R, Tomaras GD, Blattner WA, Goepfert PA, Kilby JM, Saag MS, Delwart EL, Busch MP, Cohen MS, Montefiori DC, Haynes BF, Gaschen B, Athreya GS, Lee HY, Wood N, Seoighe C, Perelson AS, Bhattacharya T, Korber BT, Hahn BH, Shaw GM: Identification and characterisation of transmitted and early founder virus envelopes in primary HIV-1 infection. Proceedings of the National Academy of Sciences of the United States of America 2008,105(21):7552-7557. 10.1073/pnas.0802203105PubMedCentralPubMed
24.
go back to reference Pilcher CD, Joaki G, Hoffman IF, Martinson FEA, Mapanje C, Stewart PW, Powers KA, Galvin S, Chilongozi D, Gama S, Price MA, Fiscus SA, Cohen MS: Amplified transmission of HIV-1: comparison of HIV-1 concentrations in semen and blood during acute and chronic infection. Aids 2007,21(13):1723-1730. 10.1097/QAD.0b013e3281532c82PubMedCentralPubMed Pilcher CD, Joaki G, Hoffman IF, Martinson FEA, Mapanje C, Stewart PW, Powers KA, Galvin S, Chilongozi D, Gama S, Price MA, Fiscus SA, Cohen MS: Amplified transmission of HIV-1: comparison of HIV-1 concentrations in semen and blood during acute and chronic infection. Aids 2007,21(13):1723-1730. 10.1097/QAD.0b013e3281532c82PubMedCentralPubMed
25.
go back to reference Rambaut A, Posada D, Crandall KA, Holmes EC: The causes and consequences of HIV evolution. Nature Reviews Genetics 2004,5(1):52-61. 10.1038/nrg1246PubMed Rambaut A, Posada D, Crandall KA, Holmes EC: The causes and consequences of HIV evolution. Nature Reviews Genetics 2004,5(1):52-61. 10.1038/nrg1246PubMed
26.
go back to reference Leslie AJ, Pfafferott KJ, Chetty P, Draenert R, Addo MM, Feeney M, Tang Y, Holmes EC, Allen T, Prado JG, Altfeld M, Brander C, Dixon C, Ramduth D, Jeena P, Thomas SA, St John A, Roach TA, Kupfer B, Luzzi G, Edwards A, Taylor G, Lyall H, Tudor-Williams G, Novelli V, Martinez-Picado J, Kiepiela P, Walker BD, Goulder PJR: HIV evolution: CTL escape mutation and reversion after transmission. Nature Medicine 2004,10(3):282-289. 10.1038/nm992PubMed Leslie AJ, Pfafferott KJ, Chetty P, Draenert R, Addo MM, Feeney M, Tang Y, Holmes EC, Allen T, Prado JG, Altfeld M, Brander C, Dixon C, Ramduth D, Jeena P, Thomas SA, St John A, Roach TA, Kupfer B, Luzzi G, Edwards A, Taylor G, Lyall H, Tudor-Williams G, Novelli V, Martinez-Picado J, Kiepiela P, Walker BD, Goulder PJR: HIV evolution: CTL escape mutation and reversion after transmission. Nature Medicine 2004,10(3):282-289. 10.1038/nm992PubMed
27.
go back to reference Chopera DR, Woodman Z, Mlisana K, Mlotshwa M, Martin DP, Seoighe C, Treurnicht F, de Rosa DA, Hide W, Karim SA, Gray CM, Williamson C: Transmission of HIV-1CTL escape variants provides HLA-mismatched recipients with a survival advantage. Plos Pathogens 2008.,4(3): Chopera DR, Woodman Z, Mlisana K, Mlotshwa M, Martin DP, Seoighe C, Treurnicht F, de Rosa DA, Hide W, Karim SA, Gray CM, Williamson C: Transmission of HIV-1CTL escape variants provides HLA-mismatched recipients with a survival advantage. Plos Pathogens 2008.,4(3):
28.
go back to reference Friedrich TC, Dodds EJ, Yant LJ, Vojnov L, Rudersdorf R, Cullen C, Evans DT, Desrosiers RC, Mothe BR, Sidney J, Sette A, Kunstman K, Wolinsky S, Piatak M, Lifson J, Hughes AL, Wilson N, O'Connor DH, Watkins DI: Reversion of CTL escape-variant immunodeficiency viruses in vivo. Nature Medicine 2004,10(3):275-281. 10.1038/nm998PubMed Friedrich TC, Dodds EJ, Yant LJ, Vojnov L, Rudersdorf R, Cullen C, Evans DT, Desrosiers RC, Mothe BR, Sidney J, Sette A, Kunstman K, Wolinsky S, Piatak M, Lifson J, Hughes AL, Wilson N, O'Connor DH, Watkins DI: Reversion of CTL escape-variant immunodeficiency viruses in vivo. Nature Medicine 2004,10(3):275-281. 10.1038/nm998PubMed
29.
go back to reference Frost SDW, Liu Y, Pond SLK, Chappey C, Wrin T, Petropoulos CJ, Little SJ, Richman DD: Characterization of human immunodeficiency virus type 1 (HIV-1) envelope variation and neutralizing antibody responses during transmission of HIV-1 subtype B. Journal of Virology 2005,79(10):6523-6527. 10.1128/JVI.79.10.6523-6527.2005PubMedCentralPubMed Frost SDW, Liu Y, Pond SLK, Chappey C, Wrin T, Petropoulos CJ, Little SJ, Richman DD: Characterization of human immunodeficiency virus type 1 (HIV-1) envelope variation and neutralizing antibody responses during transmission of HIV-1 subtype B. Journal of Virology 2005,79(10):6523-6527. 10.1128/JVI.79.10.6523-6527.2005PubMedCentralPubMed
30.
go back to reference Derdeyn CA, Decker JM, Bibollet-Ruche F, Mokili JL, Muldoon M, Denham SA, Heil ML, Kasolo F, Musonda R, Hahn BH, Shaw GM, Korber BT, Allen S, Hunter E: Envelope-constrained neutralization-sensitive HIV-1 after heterosexual transmission. Science 2004,303(5666):2019-2022. 10.1126/science.1093137PubMed Derdeyn CA, Decker JM, Bibollet-Ruche F, Mokili JL, Muldoon M, Denham SA, Heil ML, Kasolo F, Musonda R, Hahn BH, Shaw GM, Korber BT, Allen S, Hunter E: Envelope-constrained neutralization-sensitive HIV-1 after heterosexual transmission. Science 2004,303(5666):2019-2022. 10.1126/science.1093137PubMed
31.
go back to reference Lemey P, Rambaut A, Pybus OG: HIV evolutionary dynamics within and among hosts. Aids Reviews 2006,8(3):125-140.PubMed Lemey P, Rambaut A, Pybus OG: HIV evolutionary dynamics within and among hosts. Aids Reviews 2006,8(3):125-140.PubMed
32.
go back to reference Gandhi RT, Wurcel A, Rosenberg ES, Johnston MN, Hellmann N, Bates M, Hirsch MS, Walker BD: Progressive Reversion of Human Immunodeficiency Virus Type 1 Resistance Mutations In Vivo after Transmission of a Multiply Drug-Resistant Virus. Clinical Infectious Diseases 2003,37(12):1693-1698. 10.1086/379773PubMed Gandhi RT, Wurcel A, Rosenberg ES, Johnston MN, Hellmann N, Bates M, Hirsch MS, Walker BD: Progressive Reversion of Human Immunodeficiency Virus Type 1 Resistance Mutations In Vivo after Transmission of a Multiply Drug-Resistant Virus. Clinical Infectious Diseases 2003,37(12):1693-1698. 10.1086/379773PubMed
33.
go back to reference Brockman MA, Schneidewind A, Lahaie M, Schmidt A, Miura T, DeSouza I, Ryvkin F, Derdeyn CA, Allen S, Hunter E, Mulenga J, Goepfert PA, Walker BD, Allen TM: Escape and Compensation from Early HLA-B57-Mediated Cytotoxic T-Lymphocyte Pressure on Human Immunodeficiency Virus Type 1 Gag Alter Capsid Interactions with Cyclophilin A. J Virol 2007,81(22):12608-12618. 10.1128/JVI.01369-07PubMedCentralPubMed Brockman MA, Schneidewind A, Lahaie M, Schmidt A, Miura T, DeSouza I, Ryvkin F, Derdeyn CA, Allen S, Hunter E, Mulenga J, Goepfert PA, Walker BD, Allen TM: Escape and Compensation from Early HLA-B57-Mediated Cytotoxic T-Lymphocyte Pressure on Human Immunodeficiency Virus Type 1 Gag Alter Capsid Interactions with Cyclophilin A. J Virol 2007,81(22):12608-12618. 10.1128/JVI.01369-07PubMedCentralPubMed
34.
go back to reference Shriner D, Rodrigo AG, Nickle DC, Mullins JI: Pervasive genomic recombination of HIV-1 in vivo. Genetics 2004,167(4):1573-1583. 10.1534/genetics.103.023382PubMedCentralPubMed Shriner D, Rodrigo AG, Nickle DC, Mullins JI: Pervasive genomic recombination of HIV-1 in vivo. Genetics 2004,167(4):1573-1583. 10.1534/genetics.103.023382PubMedCentralPubMed
35.
go back to reference Fang GW, Weiser B, Kuiken C, Philpott SM, Rowland-Jones S, Plummer F, Kimani J, Shi BS, Kaul R, Bwayo J, Anzala O, Burger H: Recombination following superinfection by HIV-1. Aids 2004,18(2):153-159. 10.1097/00002030-200401230-00003PubMed Fang GW, Weiser B, Kuiken C, Philpott SM, Rowland-Jones S, Plummer F, Kimani J, Shi BS, Kaul R, Bwayo J, Anzala O, Burger H: Recombination following superinfection by HIV-1. Aids 2004,18(2):153-159. 10.1097/00002030-200401230-00003PubMed
36.
go back to reference Pernas M, Casado C, Fuentes R, Perez-Elias MJ, Lopez-Galindez C: A dual superinfection and recombination within HIV-1 subtype B 12 years after primoinfection. Jaids-Journal of Acquired Immune Deficiency Syndromes 2006,42(1):12-18. 10.1097/01.qai.0000214810.65292.73 Pernas M, Casado C, Fuentes R, Perez-Elias MJ, Lopez-Galindez C: A dual superinfection and recombination within HIV-1 subtype B 12 years after primoinfection. Jaids-Journal of Acquired Immune Deficiency Syndromes 2006,42(1):12-18. 10.1097/01.qai.0000214810.65292.73
37.
go back to reference Scheffler K, Martin DP, Seoighe C: Robust inference of positive selection from recombining coding sequences. Bioinformatics 2006,22(20):2493-2499. 10.1093/bioinformatics/btl427PubMed Scheffler K, Martin DP, Seoighe C: Robust inference of positive selection from recombining coding sequences. Bioinformatics 2006,22(20):2493-2499. 10.1093/bioinformatics/btl427PubMed
38.
go back to reference Anisimova M, Nielsen R, Yang ZH: Effect of recombination on the accuracy of the likelihood method for detecting positive selection at amino acid sites. Genetics 2003,164(3):1229-1236.PubMedCentralPubMed Anisimova M, Nielsen R, Yang ZH: Effect of recombination on the accuracy of the likelihood method for detecting positive selection at amino acid sites. Genetics 2003,164(3):1229-1236.PubMedCentralPubMed
39.
go back to reference Shriner D, Nickle DC, Jensen MA, Mullins JI: Potential impact of recombination on sitewise approaches for detecting positive natural selection. Genetical Research 2003,81(2):115-121. 10.1017/S0016672303006128PubMed Shriner D, Nickle DC, Jensen MA, Mullins JI: Potential impact of recombination on sitewise approaches for detecting positive natural selection. Genetical Research 2003,81(2):115-121. 10.1017/S0016672303006128PubMed
40.
go back to reference Pond SLK, Posada D, Gravenor MB, Woelk CH, Frost SDW: GARD: a genetic algorithm for recombination detection. Bioinformatics 2006,22(24):3096-3098. 10.1093/bioinformatics/btl474 Pond SLK, Posada D, Gravenor MB, Woelk CH, Frost SDW: GARD: a genetic algorithm for recombination detection. Bioinformatics 2006,22(24):3096-3098. 10.1093/bioinformatics/btl474
41.
go back to reference Martin DP, Williamson C, Posada D: RDP2: recombination detection and analysis from sequence alignments. Bioinformatics 2005,21(2):260-262. 10.1093/bioinformatics/bth490PubMed Martin DP, Williamson C, Posada D: RDP2: recombination detection and analysis from sequence alignments. Bioinformatics 2005,21(2):260-262. 10.1093/bioinformatics/bth490PubMed
42.
go back to reference Fan J, Negroni M, Robertson DL: The distribution of HIV-1 recombination breakpoints. Infection Genetics and Evolution 2007,7(6):717-723. 10.1016/j.meegid.2007.07.012 Fan J, Negroni M, Robertson DL: The distribution of HIV-1 recombination breakpoints. Infection Genetics and Evolution 2007,7(6):717-723. 10.1016/j.meegid.2007.07.012
43.
go back to reference Fan J, Negroni M, Robertson DL: The distribution of HIV-1 recombination breakpoints. Infection Genetics and Evolution 2007,7(6):717-723. 10.1016/j.meegid.2007.07.012 Fan J, Negroni M, Robertson DL: The distribution of HIV-1 recombination breakpoints. Infection Genetics and Evolution 2007,7(6):717-723. 10.1016/j.meegid.2007.07.012
44.
go back to reference Jain R, Rivera MC, Moore JE, Lake JA: Horizontal gene transfer accelerates genome innovation and evolution. Molecular Biology and Evolution 2003,20(10):1598-1602. 10.1093/molbev/msg154PubMed Jain R, Rivera MC, Moore JE, Lake JA: Horizontal gene transfer accelerates genome innovation and evolution. Molecular Biology and Evolution 2003,20(10):1598-1602. 10.1093/molbev/msg154PubMed
45.
go back to reference Lefeuvre P, Lett JM, Reynaud B, Martin DP: Avoidance of Protein Fold Disruption in Natural Virus Recombinants. PLoS Pathogens 2003,3(11):e181. 10.1093/molbev/msg154 Lefeuvre P, Lett JM, Reynaud B, Martin DP: Avoidance of Protein Fold Disruption in Natural Virus Recombinants. PLoS Pathogens 2003,3(11):e181. 10.1093/molbev/msg154
46.
go back to reference Martin DP, van der Walt E, Posada D, Rybicki EP: The Evolutionary Value of Recombination Is Constrained by Genome Modularity. PLoS Genetics 2005,1(4):e51. 10.1089/aid.2005.21.98PubMedCentralPubMed Martin DP, van der Walt E, Posada D, Rybicki EP: The Evolutionary Value of Recombination Is Constrained by Genome Modularity. PLoS Genetics 2005,1(4):e51. 10.1089/aid.2005.21.98PubMedCentralPubMed
47.
go back to reference Escriu F, Fraile A, Garcia-Arenal F: Constraints to genetic exchange support gene coadaptation in a tripartite RNA virus. Plos Pathogens 2007,3(1):67-74. 10.1371/journal.ppat.0030008 Escriu F, Fraile A, Garcia-Arenal F: Constraints to genetic exchange support gene coadaptation in a tripartite RNA virus. Plos Pathogens 2007,3(1):67-74. 10.1371/journal.ppat.0030008
48.
go back to reference Choisy M, Woelk CH, Guegan JF, Robertson DL: Comparative study of adaptive molecular evolution in different human immunodeficiency virus groups and subtypes. Journal of Virology 2004,78(4):1962-1970. 10.1128/JVI.78.4.1962-1970.2004PubMedCentralPubMed Choisy M, Woelk CH, Guegan JF, Robertson DL: Comparative study of adaptive molecular evolution in different human immunodeficiency virus groups and subtypes. Journal of Virology 2004,78(4):1962-1970. 10.1128/JVI.78.4.1962-1970.2004PubMedCentralPubMed
49.
go back to reference Travers SAA, O'Connell MJ, McCormack GP, McInerney JO: Evidence for heterogeneous selective pressures in the evolution of the env gene in different human immunodeficiency virus type 1 subtypes. Journal of Virology 2005,79(3):1836-1841. 10.1128/JVI.79.3.1836-1841.2005PubMedCentralPubMed Travers SAA, O'Connell MJ, McCormack GP, McInerney JO: Evidence for heterogeneous selective pressures in the evolution of the env gene in different human immunodeficiency virus type 1 subtypes. Journal of Virology 2005,79(3):1836-1841. 10.1128/JVI.79.3.1836-1841.2005PubMedCentralPubMed
50.
go back to reference Ulmschneider MB, Sansom MSP: Amino acid distributions in integral membrane protein structures. Biochimica et Biophysica Acta-Biomembranes 2001,1512(1):1-14. 10.1016/S0005-2736(01)00299-1 Ulmschneider MB, Sansom MSP: Amino acid distributions in integral membrane protein structures. Biochimica et Biophysica Acta-Biomembranes 2001,1512(1):1-14. 10.1016/S0005-2736(01)00299-1
51.
go back to reference Cleverley DZ, Lenard J: The transmembrane domain in viral fusion: Essential role for a conserved glycine residue in vesicular stomatitis virus G protein. Proceedings of the National Academy of Sciences of the United States of America 1998,95(7):3425-3430. 10.1073/pnas.95.7.3425PubMedCentralPubMed Cleverley DZ, Lenard J: The transmembrane domain in viral fusion: Essential role for a conserved glycine residue in vesicular stomatitis virus G protein. Proceedings of the National Academy of Sciences of the United States of America 1998,95(7):3425-3430. 10.1073/pnas.95.7.3425PubMedCentralPubMed
52.
go back to reference Melikyan GB, Markosyan RM, Roth MG, Cohen FS: A single point mutation in the transmembrane (TM) domain of influenza hemagglutinin (HA) arrests fusion at room temperature at a stage prior to pore formation. Biophysical Journal 2000,78(1):58A. Melikyan GB, Markosyan RM, Roth MG, Cohen FS: A single point mutation in the transmembrane (TM) domain of influenza hemagglutinin (HA) arrests fusion at room temperature at a stage prior to pore formation. Biophysical Journal 2000,78(1):58A.
53.
go back to reference Wang SL, York J, Shu W, Stoller MO, Nunberg JH, Lu M: Interhelical interactions in the gp41 core: Implications for activation of HIV-1 membrane fusion. Biochemistry 2002,41(23):7283-7292. 10.1021/bi025648yPubMed Wang SL, York J, Shu W, Stoller MO, Nunberg JH, Lu M: Interhelical interactions in the gp41 core: Implications for activation of HIV-1 membrane fusion. Biochemistry 2002,41(23):7283-7292. 10.1021/bi025648yPubMed
54.
go back to reference Mo HM, Konstantinidis AK, Stewart KD, Dekhtyar T, Ng T, Swift K, Matayoshi ED, Kati W, Kohlbrenner W, Molla A: Conserved residues in the coiled-coil pocket of human immunodeficiency virus type 1 gp41 are essential for viral replication and interhelical interaction. Virology 2004,329(2):319-327.PubMed Mo HM, Konstantinidis AK, Stewart KD, Dekhtyar T, Ng T, Swift K, Matayoshi ED, Kati W, Kohlbrenner W, Molla A: Conserved residues in the coiled-coil pocket of human immunodeficiency virus type 1 gp41 are essential for viral replication and interhelical interaction. Virology 2004,329(2):319-327.PubMed
55.
go back to reference McCauley S, De Groot S, Mailund T, Hein J: Annotation of selection strengths in viral genomes. Bioinformatics 2007,23(22):2978-2986. 10.1093/bioinformatics/btm472PubMed McCauley S, De Groot S, Mailund T, Hein J: Annotation of selection strengths in viral genomes. Bioinformatics 2007,23(22):2978-2986. 10.1093/bioinformatics/btm472PubMed
56.
go back to reference Perrin C, Fenouillet E, Jones IM: Role of gp41 glycosylation sites in the biological activity of human immunodeficiency virus type 1 envelope glycoprotein. Virology 1998,242(2):338-345. 10.1006/viro.1997.9016PubMed Perrin C, Fenouillet E, Jones IM: Role of gp41 glycosylation sites in the biological activity of human immunodeficiency virus type 1 envelope glycoprotein. Virology 1998,242(2):338-345. 10.1006/viro.1997.9016PubMed
57.
go back to reference Newman JT, Sturgeon TJ, Gupta P, Montelaro RC: Differential functional phenotypes of two primary HIV-1 strains resulting from homologous point mutations in the LLP domains of the envelope gp41 intracytoplasmic domain. Virology 2007,367(1):102-116. 10.1016/j.virol.2007.05.027PubMedCentralPubMed Newman JT, Sturgeon TJ, Gupta P, Montelaro RC: Differential functional phenotypes of two primary HIV-1 strains resulting from homologous point mutations in the LLP domains of the envelope gp41 intracytoplasmic domain. Virology 2007,367(1):102-116. 10.1016/j.virol.2007.05.027PubMedCentralPubMed
58.
go back to reference Cabrera C, Marfil S, Garcia E, Martinez-Picado J, Bonjoch A, Bofill M, Moreno S, Ribera E, Domingo P, Clotet B, Ruiz L: Genetic evolution of gp41 reveals a highly exclusive relationship between codons 36, 38 and 43 in gp41 under long-term enfuvirtide-containing salvage regimen. Aids 2006,20(16):2075-2080. 10.1097/QAD.0b013e3280102377PubMed Cabrera C, Marfil S, Garcia E, Martinez-Picado J, Bonjoch A, Bofill M, Moreno S, Ribera E, Domingo P, Clotet B, Ruiz L: Genetic evolution of gp41 reveals a highly exclusive relationship between codons 36, 38 and 43 in gp41 under long-term enfuvirtide-containing salvage regimen. Aids 2006,20(16):2075-2080. 10.1097/QAD.0b013e3280102377PubMed
59.
go back to reference Moreno MR, Guillen J, Perez-Berna AJ, Amoros D, Gomez AI, Bernabeu A, Villalain J: Characterization of the interaction of two peptides from the n terminus of the NHR domain of HIV-1 gp41 with phospholipid membranes. Biochemistry 2007,46(37):10572-10584. 10.1021/bi700911gPubMed Moreno MR, Guillen J, Perez-Berna AJ, Amoros D, Gomez AI, Bernabeu A, Villalain J: Characterization of the interaction of two peptides from the n terminus of the NHR domain of HIV-1 gp41 with phospholipid membranes. Biochemistry 2007,46(37):10572-10584. 10.1021/bi700911gPubMed
60.
go back to reference Dedera DA, Gu RL, Ratner L: Role of Asparagine-Linked Glycosylation in Human-Immunodeficiency-Virus Type-1 Transmembrane Envelope Function. Virology 1992,187(1):377-382. 10.1016/0042-6822(92)90331-IPubMed Dedera DA, Gu RL, Ratner L: Role of Asparagine-Linked Glycosylation in Human-Immunodeficiency-Virus Type-1 Transmembrane Envelope Function. Virology 1992,187(1):377-382. 10.1016/0042-6822(92)90331-IPubMed
61.
go back to reference Fenouillet E, Jones I, Powell B, Schmitt D, Kieny MP, Gluckman JC: Functional-Role of the Glycan Cluster of the Human-Immunodeficiency-Virus Type-1 Transmembrane Glycoprotein-(Gp41) Ectodomain. Journal of Virology 1993,67(1):150-160.PubMedCentralPubMed Fenouillet E, Jones I, Powell B, Schmitt D, Kieny MP, Gluckman JC: Functional-Role of the Glycan Cluster of the Human-Immunodeficiency-Virus Type-1 Transmembrane Glycoprotein-(Gp41) Ectodomain. Journal of Virology 1993,67(1):150-160.PubMedCentralPubMed
62.
go back to reference Lee WR, Yu XF, Syu WJ, Essex M, Lee TH: Mutational Analysis of Conserved N-Linked Glycosylation Sites of Human-Immunodeficiency-Virus Type-1 Gp41. Journal of Virology 1992,66(3):1799-1803.PubMedCentralPubMed Lee WR, Yu XF, Syu WJ, Essex M, Lee TH: Mutational Analysis of Conserved N-Linked Glycosylation Sites of Human-Immunodeficiency-Virus Type-1 Gp41. Journal of Virology 1992,66(3):1799-1803.PubMedCentralPubMed
63.
go back to reference Zwick MB, Jensen R, Church S, Wang M, Stiegler G, Kunert R, Katinger H, Burton DR: Anti-human immunodeficiency virus type 1 (HIV-1) antibodies 2F5 and 4E10 require surprisingly few crucial residues in the membrane-proximal external region of glycoprotein gp41 to neutralize HIV-1. Journal of Virology 2005,79(2):1252-1261. 10.1128/JVI.79.2.1252-1261.2005PubMedCentralPubMed Zwick MB, Jensen R, Church S, Wang M, Stiegler G, Kunert R, Katinger H, Burton DR: Anti-human immunodeficiency virus type 1 (HIV-1) antibodies 2F5 and 4E10 require surprisingly few crucial residues in the membrane-proximal external region of glycoprotein gp41 to neutralize HIV-1. Journal of Virology 2005,79(2):1252-1261. 10.1128/JVI.79.2.1252-1261.2005PubMedCentralPubMed
64.
go back to reference Lu L, Zhu Y, Huang JH, Chen X, Yang HW, Jiang SB, Chen YH: Surface exposure of the HIV-1 Env cytoplasmic tail LLP2 domain during the membrane fusion process – Interaction with gp41 fusion core. Journal of Biological Chemistry 2008,283(24):16723-16731. 10.1074/jbc.M801083200PubMedCentralPubMed Lu L, Zhu Y, Huang JH, Chen X, Yang HW, Jiang SB, Chen YH: Surface exposure of the HIV-1 Env cytoplasmic tail LLP2 domain during the membrane fusion process – Interaction with gp41 fusion core. Journal of Biological Chemistry 2008,283(24):16723-16731. 10.1074/jbc.M801083200PubMedCentralPubMed
65.
go back to reference Gandhi RT, Wurcel A, Rosenberg ES, Johnston MN, Hellmann N, Bates M, Hirsch MS, Walker BD: Progressive Reversion of Human Immunodeficiency Virus Type 1 Resistance Mutations In Vivo after Transmission of a Multiply Drug-Resistant Virus. Clinical Infectious Diseases 2003,37(12):1693-1698. 10.1086/379773PubMed Gandhi RT, Wurcel A, Rosenberg ES, Johnston MN, Hellmann N, Bates M, Hirsch MS, Walker BD: Progressive Reversion of Human Immunodeficiency Virus Type 1 Resistance Mutations In Vivo after Transmission of a Multiply Drug-Resistant Virus. Clinical Infectious Diseases 2003,37(12):1693-1698. 10.1086/379773PubMed
66.
go back to reference Brockman MA, Schneidewind A, Lahaie M, Schmidt A, Miura T, DeSouza I, Ryvkin F, Derdeyn CA, Allen S, Hunter E, Mulenga J, Goepfert PA, Walker BD, Allen TM: Escape and Compensation from Early HLA-B57-Mediated Cytotoxic T-Lymphocyte Pressure on Human Immunodeficiency Virus Type 1 Gag Alter Capsid Interactions with Cyclophilin A. J Virol 2007,81(22):12608-12618. 10.1128/JVI.01369-07PubMedCentralPubMed Brockman MA, Schneidewind A, Lahaie M, Schmidt A, Miura T, DeSouza I, Ryvkin F, Derdeyn CA, Allen S, Hunter E, Mulenga J, Goepfert PA, Walker BD, Allen TM: Escape and Compensation from Early HLA-B57-Mediated Cytotoxic T-Lymphocyte Pressure on Human Immunodeficiency Virus Type 1 Gag Alter Capsid Interactions with Cyclophilin A. J Virol 2007,81(22):12608-12618. 10.1128/JVI.01369-07PubMedCentralPubMed
67.
go back to reference van Loggerenberg F, Mlisana K, Williamson C, Auld SC, Morris L, Gray CM, bdool Karim Q, Grobler A, Barnabas N, Iriogbe I, bdool Karim SS: Establishing a Cohort at High Risk of HIV Infection in South Africa : Challenges and Experiences of the CAPRISA 002 Acute Infection Study. PLoS ONE 2008,3(4):e1954. 10.1371/journal.pone.0001954PubMedCentralPubMed van Loggerenberg F, Mlisana K, Williamson C, Auld SC, Morris L, Gray CM, bdool Karim Q, Grobler A, Barnabas N, Iriogbe I, bdool Karim SS: Establishing a Cohort at High Risk of HIV Infection in South Africa : Challenges and Experiences of the CAPRISA 002 Acute Infection Study. PLoS ONE 2008,3(4):e1954. 10.1371/journal.pone.0001954PubMedCentralPubMed
68.
go back to reference Rousseau CM, Birditt BA, Mckay AR, Stoddard JN, Lee TC, McLaughlin S, Moore SW, Shindo N, Learn GH, Korber BT, Brander C, Goulder PJR, Kiepiela P, Walker BD, Mullins JI: Large-scale amplification, cloning and sequencing of near full-length HIV-1 subtype C genomes. Journal of Virological Methods 2006,136(1–2):118-125. 10.1016/j.jviromet.2006.04.009PubMed Rousseau CM, Birditt BA, Mckay AR, Stoddard JN, Lee TC, McLaughlin S, Moore SW, Shindo N, Learn GH, Korber BT, Brander C, Goulder PJR, Kiepiela P, Walker BD, Mullins JI: Large-scale amplification, cloning and sequencing of near full-length HIV-1 subtype C genomes. Journal of Virological Methods 2006,136(1–2):118-125. 10.1016/j.jviromet.2006.04.009PubMed
69.
go back to reference Gao F, Morrison SG, Robertson DL, Thornton CL, Craig S, Karlsson G, Sodroski J, Morgado M, GalvaoCastro B, vonBriesen H, Beddows S, Weber J, Sharp PM, Shaw GM, Hahn BH, Osmanov S, Heyward WL, Esparza J, vandePerre P, Karita E, Sempala S, Tugume B, Biryahwaho B, Wasi C, RubsamenWaigmann H, Holmes H, Newberry A, Ranjbar S, Tomlinson P, Bradac J, Mullins JI, Delwart EL, CheingsongPopov R, Kaleebu P, Myers G, Korber BTM, Chiphangwi J, Taha T, Desormeaux J, Eiumtrakul S, Natpratan C, Khamboonruang C, Miotti P, Halsey NA, Vlahov D, Nelson KE, Phair J, Cao Y, Moore JP, Ho DD, Matocha M, Fowler A, Dilworth S, Sharma O, Brown R, Dusing S, Whitman J, Hoekzema D, Vogel F: Molecular cloning and analysis of functional envelope genes from human immunodeficiency virus type 1 sequence subtypes A through G. Journal of Virology 1996,70(3):1651-1667.PubMedCentralPubMed Gao F, Morrison SG, Robertson DL, Thornton CL, Craig S, Karlsson G, Sodroski J, Morgado M, GalvaoCastro B, vonBriesen H, Beddows S, Weber J, Sharp PM, Shaw GM, Hahn BH, Osmanov S, Heyward WL, Esparza J, vandePerre P, Karita E, Sempala S, Tugume B, Biryahwaho B, Wasi C, RubsamenWaigmann H, Holmes H, Newberry A, Ranjbar S, Tomlinson P, Bradac J, Mullins JI, Delwart EL, CheingsongPopov R, Kaleebu P, Myers G, Korber BTM, Chiphangwi J, Taha T, Desormeaux J, Eiumtrakul S, Natpratan C, Khamboonruang C, Miotti P, Halsey NA, Vlahov D, Nelson KE, Phair J, Cao Y, Moore JP, Ho DD, Matocha M, Fowler A, Dilworth S, Sharma O, Brown R, Dusing S, Whitman J, Hoekzema D, Vogel F: Molecular cloning and analysis of functional envelope genes from human immunodeficiency virus type 1 sequence subtypes A through G. Journal of Virology 1996,70(3):1651-1667.PubMedCentralPubMed
70.
go back to reference Kiepiela P, Leslie AJ, Honeyborne I, Ramduth D, Thobakgale C, Chetty S, Rathnavalu P, Moore C, Pfafferott KJ, Hilton L, Zimbwa P, Moore S, Allen T, Brander C, Addo MM, Altfeld M, James I, Mallal S, Bunce M, Barber LD, Szinger J, Day C, Klenerman P, Mullins J, Korber B, Coovadia HM, Walker BD, Goulder PJR: Dominant influence of HLA-B in mediating the potential co-evolution of HIV and HLA. Nature 2004,432(7018):769-774. 10.1038/nature03113PubMed Kiepiela P, Leslie AJ, Honeyborne I, Ramduth D, Thobakgale C, Chetty S, Rathnavalu P, Moore C, Pfafferott KJ, Hilton L, Zimbwa P, Moore S, Allen T, Brander C, Addo MM, Altfeld M, James I, Mallal S, Bunce M, Barber LD, Szinger J, Day C, Klenerman P, Mullins J, Korber B, Coovadia HM, Walker BD, Goulder PJR: Dominant influence of HLA-B in mediating the potential co-evolution of HIV and HLA. Nature 2004,432(7018):769-774. 10.1038/nature03113PubMed
71.
go back to reference Thompson JD, Higgins DG, Gibson TJ: CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice. Nucl Acids Res 1994,22(22):4673-4680. 10.1093/nar/22.22.4673PubMedCentralPubMed Thompson JD, Higgins DG, Gibson TJ: CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice. Nucl Acids Res 1994,22(22):4673-4680. 10.1093/nar/22.22.4673PubMedCentralPubMed
72.
go back to reference Heath L, Walt E, Varsani A, Martin DP: Recombination patterns in aphthoviruses mirror those found in other picornaviruses. Journal of Virology 2006,80(23):11827-11832. 10.1128/JVI.01100-06PubMedCentralPubMed Heath L, Walt E, Varsani A, Martin DP: Recombination patterns in aphthoviruses mirror those found in other picornaviruses. Journal of Virology 2006,80(23):11827-11832. 10.1128/JVI.01100-06PubMedCentralPubMed
73.
go back to reference Martin D, Rybicki E: RDP: detection of recombination amongst aligned sequences. Bioinformatics 2000,16(6):562-563. 10.1093/bioinformatics/16.6.562PubMed Martin D, Rybicki E: RDP: detection of recombination amongst aligned sequences. Bioinformatics 2000,16(6):562-563. 10.1093/bioinformatics/16.6.562PubMed
74.
go back to reference Padidam M, Sawyer S, Fauquet CM: Possible emergence of new geminiviruses by frequent recombination. Virology 1999,265(2):218-225. 10.1006/viro.1999.0056PubMed Padidam M, Sawyer S, Fauquet CM: Possible emergence of new geminiviruses by frequent recombination. Virology 1999,265(2):218-225. 10.1006/viro.1999.0056PubMed
75.
go back to reference Smith JM: Analyzing the Mosaic Structure of Genes. Journal of Molecular Evolution 1992,34(2):126-129.PubMed Smith JM: Analyzing the Mosaic Structure of Genes. Journal of Molecular Evolution 1992,34(2):126-129.PubMed
76.
go back to reference Posada D, Crandall KA: Evaluation of methods for detecting recombination from DNA sequences: Computer simulations. Proceedings of the National Academy of Sciences of the United States of America 2001,98(24):13757-13762. 10.1073/pnas.241370698PubMedCentralPubMed Posada D, Crandall KA: Evaluation of methods for detecting recombination from DNA sequences: Computer simulations. Proceedings of the National Academy of Sciences of the United States of America 2001,98(24):13757-13762. 10.1073/pnas.241370698PubMedCentralPubMed
77.
go back to reference Gibbs MJ, Armstrong JS, Gibbs AJ: Sister-Scanning: a Monte Carlo procedure for assessing signals in recombinant sequences. Bioinformatics 2000,16(7):573-582. 10.1093/bioinformatics/16.7.573PubMed Gibbs MJ, Armstrong JS, Gibbs AJ: Sister-Scanning: a Monte Carlo procedure for assessing signals in recombinant sequences. Bioinformatics 2000,16(7):573-582. 10.1093/bioinformatics/16.7.573PubMed
78.
go back to reference Boni MF, Posada D, Feldman MW: An exact nonparametric method for inferring mosaic structure in sequence triplets. Genetics 2007,176(2):1035-1047. 10.1534/genetics.106.068874PubMedCentralPubMed Boni MF, Posada D, Feldman MW: An exact nonparametric method for inferring mosaic structure in sequence triplets. Genetics 2007,176(2):1035-1047. 10.1534/genetics.106.068874PubMedCentralPubMed
79.
go back to reference Pupko T, Galtier N: A covarion-based method for detecting molecular adaptation: application to the evolution of primate mitochondrial genomes. Proceedings of the Royal Society of London Series B-Biological Sciences 2002,269(1498):1313-1316. 10.1098/rspb.2002.2025 Pupko T, Galtier N: A covarion-based method for detecting molecular adaptation: application to the evolution of primate mitochondrial genomes. Proceedings of the Royal Society of London Series B-Biological Sciences 2002,269(1498):1313-1316. 10.1098/rspb.2002.2025
80.
go back to reference Pond SLK, Frost SDW: Datamonkey: rapid detection of selective pressure on individual sites of codon alignments. Bioinformatics 2005,21(10):2531-2533. 10.1093/bioinformatics/bti320PubMed Pond SLK, Frost SDW: Datamonkey: rapid detection of selective pressure on individual sites of codon alignments. Bioinformatics 2005,21(10):2531-2533. 10.1093/bioinformatics/bti320PubMed
81.
go back to reference Pond SLK, Frost SDW, Grossman Z, Gravenor MB, Richman DD, Brown AJL: Adaptation to different human populations by HIV-1 revealed by codon-based analyses. PLoS Comput Biol 2006,2(6):e62-. 10.1371/journal.pcbi.0020062PubMed Pond SLK, Frost SDW, Grossman Z, Gravenor MB, Richman DD, Brown AJL: Adaptation to different human populations by HIV-1 revealed by codon-based analyses. PLoS Comput Biol 2006,2(6):e62-. 10.1371/journal.pcbi.0020062PubMed
82.
go back to reference Sokal RR, Michener CD: A statistical method for evaluating systematic relationships. Univ Kans Sci Bull 1958, 28: 1409-1438. Sokal RR, Michener CD: A statistical method for evaluating systematic relationships. Univ Kans Sci Bull 1958, 28: 1409-1438.
83.
go back to reference Saitou N, Nei M: The Neighbor-Joining Method – A New Method for Reconstructing Phylogenetic Trees. Mol Biol Evol 1986,4(4):406-425. Saitou N, Nei M: The Neighbor-Joining Method – A New Method for Reconstructing Phylogenetic Trees. Mol Biol Evol 1986,4(4):406-425.
84.
go back to reference Wong WSW, Yang ZH, Goldman N, Nielsen R: Accuracy and power of statistical methods for detecting adaptive evolution in protein coding sequences and for identifying positively selected sites. Genetics 2004,168(2):1041-1051. 10.1534/genetics.104.031153PubMedCentralPubMed Wong WSW, Yang ZH, Goldman N, Nielsen R: Accuracy and power of statistical methods for detecting adaptive evolution in protein coding sequences and for identifying positively selected sites. Genetics 2004,168(2):1041-1051. 10.1534/genetics.104.031153PubMedCentralPubMed
85.
go back to reference Brodsky LI, Ivanov VV, Kalaydzidis YL, Leontovich AM, Nikolaev VK, Feranchuk SI, Drachev VA: Genebee-Net – Internet-Based Server for Analyzing Biopolymers Structure. Biochemistry-Moscow 1995,60(8):923-928. Brodsky LI, Ivanov VV, Kalaydzidis YL, Leontovich AM, Nikolaev VK, Feranchuk SI, Drachev VA: Genebee-Net – Internet-Based Server for Analyzing Biopolymers Structure. Biochemistry-Moscow 1995,60(8):923-928.
86.
go back to reference Zhang M, Gaschen B, Blay W, Foley B, Haigwood N, Kuiken C, Korber B: Tracking global patterns of N-linked glycosylation site variation in highly variable viral glycoproteins: HIV, SIV, and HCV envelopes and influenza hemagglutinin. Glycobiology 2004,14(12):1229-1246. 10.1093/glycob/cwh106PubMed Zhang M, Gaschen B, Blay W, Foley B, Haigwood N, Kuiken C, Korber B: Tracking global patterns of N-linked glycosylation site variation in highly variable viral glycoproteins: HIV, SIV, and HCV envelopes and influenza hemagglutinin. Glycobiology 2004,14(12):1229-1246. 10.1093/glycob/cwh106PubMed
Metadata
Title
Conserved positive selection signals in gp41 across multiple subtypes and difference in selection signals detectable in gp41 sequences sampled during acute and chronic HIV-1 subtype C infection
Authors
Gama P Bandawe
Darren P Martin
Florette Treurnicht
Koleka Mlisana
Salim S Abdool Karim
Carolyn Williamson
The CAPRISA 002 Acute Infection Study Team
Publication date
01-12-2008
Publisher
BioMed Central
Published in
Virology Journal / Issue 1/2008
Electronic ISSN: 1743-422X
DOI
https://doi.org/10.1186/1743-422X-5-141

Other articles of this Issue 1/2008

Virology Journal 1/2008 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.